Some studies have shown that high HER2 expression indicated high viability, proliferation and invasive ability in tumor cells, in addition, increased drug resistance mediated by HER2 expression was an important factor for the tumor malignancy and poor patient prognosis (11). This evidence concerns the gene ERBB2 and neoplasm.